study Archives - AudioMedica.com

Tagged: study

0
- in Public Health
- — 28 May, 2008
Blind For Blindness: Preventing Childhood Blindness

Hessom Razavi, Puneet Sayal, Claire Gilbert
Hessom Razavi, Puneet Sayal, Claire Gilbert, London School of Hygiene and Tropical Medicine
Eye doctor Hessom Razavi volunteered to go about his usual studies at the London School blindfold for 24 hours to
…
Read more
2
- in Cardiovascular
- — 30 Apr, 2008
Bivalirudin For Angioplasty: Expensive Heparin?
Tony Gershlick
Tony Gershlick, University of Leicester
Adnan Kastrati, Deutsches Herzzentrum, Munich
Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing death, MI or urgent revascularisation in the 4,500-patient ISAR-REACT 3 study presented at the
…
Read more
0
- in Cardiovascular
- — 8 Apr, 2008
Never Too Old For Hypertension Treatment!

Nigel Beckett

Nick Boon
Nigel Beckett, Imperial College, London
COMMENT: Nick Boon, British Cardiovascular Society, London
Even very old patients benefit greatly if you treat their hypertension. This is the finding of the randomized HYVET study of 4,000 patients with
…
Read more
0
- in Oncology
- — 16 Mar, 2008
Bevacizumab: New Standard for Non-Small Cell Lung Cancer?

Christian Manegold

Nick Thatcher
Christian Manegold, Heidelberg University Medical Center, Manheim
Nick Thatcher, Christie Hospital, Manchester
Is bevacizumab a new standard of care for patients with unresectable non-small cell lung cancer who have good performance status? This question
…
Read more
0
- in News
- — 16 Mar, 2008
Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer

Robert Pirker
ROBERT PIRKER , Medical University of Vienna
Phase III study results have detected improvements in overall survival among patients with advanced non-small cell lung cancer treated with a monoclonal antibody targeted to the epidermal growth factor receptor: EGFR.
…
Read more
0
- in News
- — 16 Mar, 2008
Lung Cancer Screening: Wait for Prospective Study Findings!

Ugo Pastorino
UGO PASTORINO , Istituto Nazionale Tumori, Milan
Even the most sophisticated and powerful detection method for lung cancer detection, spiral CT, is still unproven in the context of mass screening for lung cancer. At the conference in Turin,
…
Read more
0
- in Public Health
- — 17 Jan, 2008
London School of Hygiene & Tropical Medicine Audio News – Undernutrirtion Causes a Third of Child Deaths

Zulfiqar Bhutta
Reference: The Lancet, Maternal and Child Undernutrition Special Series
With one child in three killed by it, childhood and maternal undernutrition are discussed in a special series of articles in the Lancet. Sarah Maxwell spoke with Zulfiqar Bhutta
…
Read more
0
- in General Medicine
- — 4 Jan, 2008
Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability

Peter Tyrer
REFERENCE: Lancet 371:57 January 5, 2008
PETER TYRER, Imperial College, W6 8RP London
A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients who have intellectual disability presenting with a syndrome commonly labelled as
…
Read more
Ibritumomab Provides Benefit in Patients with Follicular Lymphoma" /> 0
- in Oncology
- — 11 Dec, 2007
Live Report from ASH:
Ibritumomab Provides Benefit in Patients with Follicular Lymphoma

Anton Hagenbeek
ANTON HAGENBEEK, University Medical Centre Utrecht
For patients with advanced-stage follicular non-Hodgkinâ€™s lymphoma, ibritumomab tiuxetan seems to prolong progression free survival by two years with favourable toxicity. Sarah Maxwell spoke to study author Anton Hagenbeek at the ASH
…
Read more
Can Intensive Immunochemotherapy Cure Mantle Cell Lymphoma?" /> 0
- in Oncology
- — 11 Dec, 2007
Live Report from ASH:
Can Intensive Immunochemotherapy Cure Mantle Cell Lymphoma?

Christian Geisler
CHRISTIAN GEISLER, Rigshospitalet, Copenhagen
Mantle cell lymphoma, which was previously considered incurable, has apparently been cured in some patients on a phase II study. Derek Thorne got the details on the study â€“ which featured an intensive immunochemotherapy
…
Read more
0
- in Oncology
- — 10 Dec, 2007
Live Report from ASH: Azacitidine â€˜New Standardâ€™ In High Risk Myelodysplastic Syndromes

Pierre Fenaux
PIERRE FENAUX, Paris 13 University
Results from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with high-risk MDS. Pierre Fenaux of Paris 13 University
…
Read more
1
- in General Medicine
- — 9 Dec, 2007
New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura

Terry Gernsheimer
TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial
…
Read more

Tagged: study

Sign up for AudioMedica.com news